Atroventhfa
Product Images NDC 54868-5511

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atroventhfa (NDC 54868-5511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atrovent Hfa (ipratropium Bromide Hfa) Inhalation Aerosol (5511)

Packaging label for AtroventHFA oral inhaler distributed by Physicians Total Care, Inc. The label shows the product NDC 54868-5511-0, batch lot number 0000, and an expiration date of 01/60. It also includes barcode details and manufacturing location information.*

FDA Label Image

Atrovent Figure (Day 1)

Two line graphs depicting FEV1 (liters) over time (hours after drug administration) for Day 1 and Day 85. The graphs compare the effects of placebo, ipratropium bromide HFA 42 mcg, ipratropium bromide HFA 84 mcg, and ipratropium bromide CFC 42 mcg on lung function.*

FDA Label Image

Atrovent Diag. 1 (Atroventhfa Pic1)

An instructional diagram illustrating the components of an AtroventHFA inhaler. It labels the parts as canister, mouthpiece, and dustcap, showing the assembly of the inhaler device.*

FDA Label Image

Atrovent Diag. 2 (Atroventhfa Pic2)

An instructional illustration showing a person using an Atrovent HFA inhaler. The image depicts proper hand and mouth positioning to administer a dose from the inhaler.*

FDA Label Image

Atrovent Diag. 3 (Atroventhfa Pic3)

An instructional diagram showing a person using Atrovent HFA inhaler. The illustration depicts the user holding the inhaler upright and inserting the mouthpiece into the mouth, demonstrating proper inhalation technique for Atrovent HFA.*

FDA Label Image

Atrovent Diag. 4 (Atroventhfa Pic4)

An instructional illustration showing a person using the Atrovent HFA inhaler. The diagram depicts the correct positioning of the inhaler near the mouth, emphasizing proper inhaler use technique for optimal medication delivery.*

FDA Label Image

Atrovent Diag. 5 (Atroventhfa Pic5)

An instructional diagram illustrating a hand shaking a pressurized inhaler canister, likely to demonstrate proper use or preparation of an Atrovent HFA inhaler.*

FDA Label Image

Atrovent Structure (Atroventhfa Struct)

Chemical structure of the active ingredient in AtroventHFA, depicting the molecular arrangement including the tropane ring and associated functional groups along with bromide and water components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.